CMO Summit - BIA update, Keynote presentation, Role of a Chief Medical Officer.pdf

Welcome and scene setting

Steve Bates OBE, Chief Executive Officer, BioIndustry Association

Opening keynote address

Dr Louise Wood, Director of Science, Research & Evidence, Department of Health

The role of a Chief Medical Officer

The role of Chief Medical Officer (CMO) is evolving in response to the requirement for biotechnology and pharmaceutical companies to apply more ethical and scientific rigor to decision making, driven by both the public and the broader medical community. This session will explore this changing role from the point of view of the ‘Investor’, the ‘Regulator’ and the CMO him/herself.

Chairperson: Dr Glen Clack, University of Sheffield

View from Investors – what they want from a CMO

Dr Hamish Cameron, SC Life Sciences

View from a regulatory perspective – what they need from a CMO

Dr David Jefferys, Eisai

View from the coalface – what is expected

Dr Penny Ward, Karus Therapeutics